| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-20 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-17 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |